Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-suicidal effects of IV ketamine in a real-world setting.
O'Brien B, Lee J, Kim S, Nandra GS, Pannu P, Tamman A, Amarneh D, Swann AC, Murphy N, Averill L, Jha M, Mathew SJ. O'Brien B, et al. Among authors: averill l. Psychiatry Res. 2024 Jan;331:115604. doi: 10.1016/j.psychres.2023.115604. Epub 2023 Nov 14. Psychiatry Res. 2024. PMID: 38064911
Neural complexity EEG biomarkers of rapid and post-rapid ketamine effects in late-life treatment-resistant depression: a randomized control trial.
Murphy N, Tamman AJF, Lijffijt M, Amarneh D, Iqbal S, Swann A, Averill LA, O'Brien B, Mathew SJ. Murphy N, et al. Among authors: averill la. Neuropsychopharmacology. 2023 Oct;48(11):1586-1593. doi: 10.1038/s41386-023-01586-4. Epub 2023 Apr 19. Neuropsychopharmacology. 2023. PMID: 37076582 Free PMC article. Clinical Trial.
Correction: Neural complexity EEG biomarkers of rapid and post-rapid ketamine effects in late-life treatment-resistant depression: a randomized control trial.
Murphy N, Tamman AJF, Lijffijt M, Amarneh D, Iqbal S, Swann A, Averill LA, O'Brien B, Mathew SJ. Murphy N, et al. Among authors: averill la. Neuropsychopharmacology. 2023 Oct;48(11):1699. doi: 10.1038/s41386-023-01618-z. Neuropsychopharmacology. 2023. PMID: 37349477 Free PMC article. No abstract available.
mTORC1 inhibitor effects on rapid ketamine-induced reductions in suicidal ideation in patients with treatment-resistant depression.
Averill LA, Averill CL, Gueorguieva R, Fouda S, Sherif M, Ahn KH, Ranganathan M, D'Souza DC, Southwick SM, Sanacora G, Duman RS, Krystal JH, Abdallah CG. Averill LA, et al. Among authors: averill cl. J Affect Disord. 2022 Apr 15;303:91-97. doi: 10.1016/j.jad.2022.01.104. Epub 2022 Jan 29. J Affect Disord. 2022. PMID: 35101523 Clinical Trial.
108 results